These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22136969

  • 1. Thyroid incidentalomas on fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography: incidence, malignancy risk, and comparison of standardized uptake values.
    Kao YH, Lim SS, Ong SC, Padhy AK.
    Can Assoc Radiol J; 2012 Nov; 63(4):289-93. PubMed ID: 22136969
    [Abstract] [Full Text] [Related]

  • 2. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
    Brindle R, Mullan D, Yap BK, Gandhi A.
    Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
    [Abstract] [Full Text] [Related]

  • 3. Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation.
    Hagenimana N, Dallaire J, Vallée É, Belzile M.
    J Otolaryngol Head Neck Surg; 2017 Mar 21; 46(1):22. PubMed ID: 28320460
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation.
    Pattison DA, Bozin M, Gorelik A, Hofman MS, Hicks RJ, Skandarajah A.
    J Nucl Med; 2018 May 21; 59(5):749-755. PubMed ID: 29025986
    [Abstract] [Full Text] [Related]

  • 7. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
    Chun AR, Jo HM, Lee SH, Chun HW, Park JM, Kim KJ, Jung CH, Mok JO, Kang SK, Kim CH, Kim BY.
    Endocrinol Metab (Seoul); 2015 Mar 27; 30(1):71-7. PubMed ID: 25325277
    [Abstract] [Full Text] [Related]

  • 8. [Interpretation of thyroid incidentalomas in (18)F-FDG PET/CT studies].
    Achury C, Estorch M, Domènech A, Camacho V, Flotats A, Jaller R, Geraldo L, Deportós J, Montes A, Carrió I.
    Rev Esp Med Nucl Imagen Mol; 2014 Mar 27; 33(4):205-9. PubMed ID: 24560597
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT).
    Familiar C, Merino S, Valhondo R, López C, Pérez X, De Los Monteros PE, Hernández F, Pazos M, Pallarés R, Pascual AC.
    Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar 27; 70(3):171-178. PubMed ID: 37030900
    [Abstract] [Full Text] [Related]

  • 10. A risk-adapted approach using US features and FNA results in the management of thyroid incidentalomas identified by 18F-FDG PET.
    Choi JS, Choi Y, Kim EK, Yoon JH, Youk JH, Han KH, Moon HJ, Kang WJ, Kwak JY.
    Ultraschall Med; 2014 Feb 27; 35(1):51-8. PubMed ID: 24458573
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G.
    Clin Endocrinol (Oxf); 2011 Oct 27; 75(4):528-34. PubMed ID: 21575027
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thyroid incidentalomas in FDG-PET/CT: prevalence and clinical impact.
    Bonabi S, Schmidt F, Broglie MA, Haile SR, Stoeckli SJ.
    Eur Arch Otorhinolaryngol; 2012 Dec 27; 269(12):2555-60. PubMed ID: 22298251
    [Abstract] [Full Text] [Related]

  • 17. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K.
    Nucl Med Commun; 2016 Dec 27; 37(12):1290-1296. PubMed ID: 27612034
    [Abstract] [Full Text] [Related]

  • 18. Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
    Hassan A, Riaz S, Zafar W.
    Nucl Med Commun; 2016 Oct 27; 37(10):1069-73. PubMed ID: 27571130
    [Abstract] [Full Text] [Related]

  • 19. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, Berdelou A, Lepoutre-Lussey C, Mirghani H, Baudin E, Schlumberger M, Leboulleux S.
    Thyroid; 2015 Apr 27; 25(4):437-44. PubMed ID: 25633259
    [Abstract] [Full Text] [Related]

  • 20. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C, Lin M, Chicco A, Benson R.
    Acta Radiol; 2011 Oct 01; 52(8):899-904. PubMed ID: 21873505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.